Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Clinical trial NCT05176002 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05176002
- Sponsor
- Fujian Medical University Union Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2023-09-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.